Gilead's remdesivir fails to show benefit in European trial; no fetus risk seen with first trimester vaccination - CNA


4/4/2022 12:00:00 AM3 years 1 month ago

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Two promising drugs for COVID-19 fail to deliver Two drugs that…

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Two prom… [+4022 chars]

full article...